LGHO GmbH- Laborgemeinschaft für Hämatologie und Onkologie

What LGHO GmbH- Laborgemeinschaft für Hämatologie und Onkologie does

LGHO GmbH – Laborgemeinschaft für Hämatologie und Onkologie is a privately held German pharmaceutical manufacturer founded in 1999 and headquartered in Leipzig, Saxony. The company specializes in the sterile, patient-specific production of parenteral preparations for hematology and oncology under GMP conditions, holding a manufacturing license pursuant to §13 of the German Medicines Act (Arzneimittelgesetz) and operating in cleanroom environments classified as Class A in B. Its core product portfolio includes cytostatics, monoclonal antibodies, ophthalmics, folinate, and supportive care medications, complemented by infusion systems (CONNECT Z, INFUSOMAT SPACE, INTRAFIX, AGILIA VOLUMAT lines), infusion pumps (ACCUFUSER, AUTOFUSER, SUREFUSER), and carrier solutions (EASYFLEX, GLUCOSTERIL, isotonic saline). Manufacturing is governed by validated SOPs, continuous environmental and microbiological monitoring, and rigorous personnel qualification and re-qualification protocols.

LGHO generates revenue on a transaction-fee basis by billing healthcare providers for individually prepared formulations, with separate billing streams for production, procurement, and prescription management. Its go-to-market is enterprise field sales (Außendienst) targeting hospital pharmacies and oncology practices across Germany, supplemented by a professional website with a product configurator, LinkedIn presence, and direct communication channels (toll-free hotline, fax, dedicated email). Distribution is performed via a company-owned, qualified transport fleet, and the company also holds a §52a AMG pharmaceutical wholesale license for GDP-compliant distribution of supplementary products. Customers are hospital pharmacies and oncology physician practices, with end beneficiaries being individual oncology patients receiving targeted tumor therapy. The company is led by Managing Directors Andrea Hacker and Louisa Schöpe and operates without disclosed external investors, parent companies, or subsidiaries.

Name

LGHO GmbH- Laborgemeinschaft für Hämatologie und Onkologie

Legal name

Laborgemeinschaft für Hämatologie und Onkologie GmbH

Website

https://lgho.de

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

LGHO GmbH is a Leipzig-based, GMP-certified pharmaceutical manufacturer producing patient-specific sterile parenteral preparations for oncology, serving German hospital pharmacies and oncology practices via direct field sales and its own delivery fleet since 1999.

Ownership category

akta.pro rank

Product category

Sterile Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industries

Specialty Pharmaceutical Distributors (HLAIAJAB), Direct-to-Provider / Clinic Buy-and-Bill Distributors (HLAIAJAM), GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL), Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD)

Keywords

• Sterile pharmaceutical manufacturing
• Patient-specific parenteral preparations
• GMP-certified oncology compounding
• Cytostatic drug preparation
• Cleanroom injectable production

Headquarters

HQ city

Leipzig

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Patient-Specific Pharmaceutical Manufacturing: Manufacture of sterile patient-specific parenteral pharmaceutical preparations for oncology patients, supplied to physician practices and hospital pharmacies. Revenue is generated through billing for individually prepared formulations, with separate billing for production, procurement, and prescription management (Abrechnung, Einkauf und Rezeptmanagement). The company also operates as a pharmaceutical wholesaler (Großhandel) under §52a AMG.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

LGHO GmbH manufactures patient-specific sterile parenteral pharmaceutical preparations for targeted oncology and hematology therapy in a GMP-certified Class A in B cleanroom environment, supplied to physician practices and hospital pharmacies in Germany. Beyond compounding, the company operates as a pharmaceutical wholesaler under §52a AMG, supplies infusion systems, pumps, and carrier solutions, and provides clinical study support, cytotoxic waste disposal, and direct delivery via its own qualified fleet.

Product overview

LGHO GmbH operates as a GMP-certified pharmaceutical manufacturer specializing in patient-specific sterile parenteral preparations for hematology and oncology. The core product portfolio centers on individually formulated cytostatics, monoclonal antibodies, ophthalmic products, folinate, and supportive care medications, all manufactured under aseptic cleanroom conditions (Class A in B). The company offers an extensive range of infusion systems (including CONNECT Z, INFUSOMAT SPACE, INTRAFIX, SANGOFIX, and AGILIA VOLUMAT lines), infusion pumps (ACCUFUSER, AUTOFUSER, SUREFUSER), and carrier solutions (EASYFLEX, GLUCOSTERIL, isotonic saline). Beyond manufacturing, LGHO provides complementary services including pharmaceutical consulting, clinical trial support, cytotoxic waste disposal, fleet delivery, field sales, and pharmaceutical wholesale distribution. The company holds manufacturing authorization under § 13 AMG and GMP certification.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient-Specific Sterile Parenteral Preparations (Patientenindividuelle Parenteralia) Sterile, patient-individual parenteral medications (cytostatics, monoclonal antibodies, ophthalmics, folinates, supportive preparations) compounded under GMP for targeted tumor therapy, manufactured in a Class A in B cleanroom at industrial scale and delivered to oncology practices and hospital pharmacies.
• Infusion Systems Range of sterile infusion administration sets and lines used to deliver LGHO's compounded parenteral preparations, including standard infusion sets, cytostatic administration sets, lipid-specific sets, in-line 0.2 micron sterile filters, and Agilia Volumat pump line sets.
• Infusion Pumps Elastomeric and automated infusion pumps (ACCUFUSER, AUTOFUSER, SUREFUSER) for continuous and controlled delivery of patient-specific chemotherapy and biologic preparations in oncology settings.
• Carrier Solutions Sterile carrier and dilution solutions used to compound and administer parenteral medications, including 5% glucose (GLUCOSTERIL), isotonic 0.9% sodium chloride, and EASYFLEX flexible 100ml empty bags.
• Pharmaceutical Wholesale Distribution (Großhandel) GDP-compliant wholesale supply of medicinal products (including infusion systems, pumps, and carrier solutions) to hospital pharmacies and oncology practices, operated under the §52a AMG wholesale license.
• Clinical Study Support Services Reliable clinical study partner providing GMP-compliant patient-specific investigational preparations with implementation of Good Clinical Practice (GCP) requirements for sponsor and CRO studies.
• Cytotoxic Waste Disposal Service Organization and support for compliant disposal of cytostatic waste and associated packaging materials generated by oncology practices and pharmacies during handling of patient-specific preparations.

Quantifiable outcome

• Sterility and pyrogen-free quality of all formulations guaranteed through intensive microbiological monitoring and cleanroom controls.
• +1 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered unclear and minor.

• SPIEunclearTechnology or IntegrationListed as a cooperation partner on the LGHO partner page. Nature of partnership is not explicitly described in available sources.
• MPSunclearTechnology or IntegrationListed as a cooperation partner on the LGHO partner page. MPS appears to be a service or technology partner, but specific partnership details are not described.
• Titus Eckert AllianzunclearStrategic or Co-development PartnerListed as a cooperation partner on the LGHO partner page. The 'Allianz' naming suggests a broader partnership or network arrangement, but details are not specified.
• EK (Ernst Kötter?)unclearOthersListed as a cooperation partner on the LGHO partner page. Full company name not clearly identifiable from the logo. No additional description available.
• Erna's DeliminorOthersListed as a cooperation partner on the LGHO partner page. Nature of partnership unclear; appears to be a local food/catering partner possibly providing workplace amenities (food services).
• DT (possibly Dataport)unclearTechnology or IntegrationListed as a cooperation partner on the LGHO partner page. Logo appears to reference DT. The full partner name is not explicitly stated in available sources.
• DEUDAT GmbHminorOthersAppointed data protection officer (Datenschutzbeauftragter) for LGHO. Located at Zehntenhofstraße 5b, 65201 Wiesbaden. Provides data protection compliance services.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• SK Pharma GmbH: German manufacturer of sterile cytostatic and infusion solutions for oncology, with GMP-certified aseptic filling. Directly comparable CDMO serving the same German oncology customer base.
• pharma k gmbh: Specialized German manufacturer of patient-specific sterile preparations, particularly infusion and injection solutions for clinics and pharmacies. Closely comparable product mix and customer profile.
• ZytoService Group GmbH: German CDMO specializing in patient-specific sterile cytostatic and oncology preparations, with multiple compounding sites. Direct competitor to LGHO in the same customer segment of oncology practices and hospital pharmacies.
• Oncotec Pharma GmbH: German pharmaceutical manufacturer producing sterile patient-specific oncology preparations and small-batch aseptic products. Direct competitor in GMP-certified oncology compounding.

Broad incumbents

• Siegfried Holding AG: Swiss-headquartered CDMO with sterile manufacturing of finished dosage forms including oncology-related products. Overlaps with LGHO in aseptic manufacturing know-how, though at significantly larger scale.
• NextPharma Technologies Holding GmbH: European CDMO offering sterile manufacturing, including aseptic filling and lyophilization. Comparable GMP-grade sterile production but with broader contract manufacturing services.
• Aenova Group: European CDMO with sterile liquid and aseptic manufacturing operations serving pharma customers. Larger contract manufacturer with comparable capabilities but at multi-site, multi-client scale.
• medac GmbH: German specialty pharmaceutical company with significant oncology and sterile manufacturing capabilities. Operates at larger scale with broader product portfolio but overlaps in cytostatic manufacturing.
• B. Braun Melsungen AG: Major German-based global medical and pharmaceutical company with infusion solutions, sterile compounding, and hospital pharmacy supply — a broad incumbent in LGHO's adjacent market segments.
• Synthon GmbH: European specialty pharmaceutical company with sterile manufacturing capability including oncology products. Larger incumbent with broader portfolio but overlapping in GMP-grade sterile production.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/lgho-gmbh-laborgemeinschaft-f%C3%BCr-h%C3%A4matologie-und-onkologie

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LGHO GmbH- Laborgemeinschaft für Hämatologie und Onkologie